Paper39598554
Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management.
Lee KR and 2 others. Pharmaceutics, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management. Papers, record 39598554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39598554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021R1I1A3056261 | National Research Foundation of Korea | PubMed | ||
| NA | KRIBB Research Initiative Program | PubMed |
Source PubMed
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16686369 | Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse. | Mol Pharm | 2006 | https://conductscience.org/library/papers/16686369 | PubMed |
| 2 | 17553913 | Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: a mechanism for possible drug interactions. | Drug Metab Dispos | 2007 | https://conductscience.org/library/papers/17553913 | PubMed |
| 3 | 10389134 | Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers. | Pediatr Transplant | 1999 | https://conductscience.org/library/papers/10389134 | PubMed |
| 4 | 28730856 | In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes. | Xenobiotica | 2018 | https://conductscience.org/library/papers/28730856 | PubMed |
| 5 | 16128682 | Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. | Aliment Pharmacol Ther | 2005 | https://conductscience.org/library/papers/16128682 | PubMed |
| 6 | 23128233 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | Nature | 2012 | https://conductscience.org/library/papers/23128233 | PubMed |
| 7 | 22169051 | Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study. | Clin Ther | 2012 | https://conductscience.org/library/papers/22169051 | PubMed |
| 8 | 19026171 | Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes. | Acta Pharmacol Sin | 2008 | https://conductscience.org/library/papers/19026171 | PubMed |
| 9 | 38050329 | Assessment of CYP3A-mediated drug interaction via cytokine (IL-6) elevation for mosunetuzumab using physiologically-based pharmacokinetic modeling. | CPT Pharmacometrics Syst Pharmacol | 2024 | https://conductscience.org/library/papers/38050329 | PubMed |
| 10 | 28124606 | Cytochrome P450 Structure, Function and Clinical Significance: A Review. | Curr Drug Targets | 2018 | https://conductscience.org/library/papers/28124606 | PubMed |
| 11 | 16633046 | 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. | Inflamm Bowel Dis | 2006 | https://conductscience.org/library/papers/16633046 | PubMed |
| 12 | 27437405 | Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications. | J Immunol Res | 2016 | https://conductscience.org/library/papers/27437405 | PubMed |
| 13 | 15819814 | Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C). | Transpl Int | 2005 | https://conductscience.org/library/papers/15819814 | PubMed |
| 14 | 34752478 | Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression. | PLoS One | 2021 | https://conductscience.org/library/papers/34752478 | PubMed |
| 15 | 31945371 | AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31945371 | PubMed |
| 16 | 20393175 | Infliximab, azathioprine, or combination therapy for Crohn's disease. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20393175 | PubMed |
| 17 | 29409871 | Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29409871 | PubMed |
| 18 | 6580097 | Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. | Clin Pharmacol Ther | 1983 | https://conductscience.org/library/papers/6580097 | PubMed |
| 19 | 32202190 | Effects of naringenin on the pharmacokinetics of tofacitinib in rats. | Pharm Biol | 2020 | https://conductscience.org/library/papers/32202190 | PubMed |
| 20 | 11600468 | Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. | Gut | 2001 | https://conductscience.org/library/papers/11600468 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819218 | Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42819218 | PubMed |
| 42745107 | Properties of Persea americana Mill (Lauraceae) kernels aqueous extract on acetic acid-induced ulcerative colitis in rats. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42745107 | PubMed |
| 42186949 | Modulation of Oxidative Stress and Nuclear Factor-κB- Associated Inflammatory Signaling by Rabeprazole in Acetic Acid-Induced Colonic Injury | Turk J Gastroenterol | 2026 | https://conductscience.org/library/papers/42186949 | PubMed |
| 41688589 | Drug-disease interactions in inflammation: mechanisms, clinical Impact, and future directions. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41688589 | PubMed |
| 40088372 | The efficacy, safety, and persistence of vedolizumab versus adalimumab in patients with inflammatory bowel disease: a systematic review and meta-analysis. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40088372 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39598554
GET https://conductscience.org/api/papers/v1/39598554/references?page=2